title: Patient selection for the surgical treatment of resectable colorectal liver metastases.
abstract: Advances in surgery and chemotherapy regimens have increased the long-term survival of patients with colorectal liver metastases (CRLM). Although liver resection remains an essential part of any curative strategy for resectable CRLM, chemotherapy regimens have also improved the long-term outcomes. However, the optimal timing for chemotherapy regimens remains unclear. Thus, this review addressed key points to aid the decision-making process regarding the timing of chemotherapy and surgery for patients with resectable CRLM. J. Surg. Oncol. 2017;115:213-220. © 2016 Wiley Periodicals, Inc.
authors: Department of Upper Gastrointestinal and Hepato-Pancreato-Biliary Surgery, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.
authors: Raphael L C
authors: RL
authors: Araujo
authors: Department of Radiology and Oncology, Instituto do Câncer do Estado de São Paulo, University of São Paulo Medical School, São Paulo, Brazil.
authors: Rachel P
authors: RP
authors: Riechelmann
authors: Department of Surgery, City of Hope National Medical Center, Duarte, California.
authors: Yuman
authors: Y
authors: Fong
mesh_terms: D015179:Colorectal Neoplasms / Q000473:pathology / Q000601:surgery*; D006498:Hepatectomy; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary / Q000601:surgery*; D018579:Patient Selection
keywords: chemotherapy; colorectal liver metastases; hepatectomy; long-term outcomes; surgery